SCHEMBL31455642

SCHEMBL31455642

COC(=O)C1CCN(C(=O)Nc2ccc(Nc3nc(-c4ccccc4)ccc3[N+](=O)[O-])cc2)C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.50
HTT P42858 2/20 0.42
TRPV1 Q8NER1 3/20 0.41
TDP1 Q9NUW8 1/20 0.40
TSHR P16473 1/20 0.39
BRD4 O60885 1/20 0.39
LMNA P02545 2/20 0.38
HPGD P15428 1/20 0.38
KMT2A Q03164 3/20 0.38
MAPT P10636 3/20 0.38
MEN1 O00255 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
MCL1 Q07820 1/20 0.38
PTK2B Q14289 1/20 0.38
FAAH O00519 1/20 0.38
KDM4E B2RXH2 1/20 0.38
NPC1 O15118 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31455342 0.95 ALDH1A1 (0.57) ALDH1A1HTTTRPV1TDP1TSHR
SCHEMBL31455623 0.86 ALDH1A1 (0.53) ALDH1A1HTTTRPV1TDP1TSHR
SCHEMBL31455312 0.84 LTA4H (0.45)
SCHEMBL31455362 0.84 ALDH1A1 (0.46) ALDH1A1HTTTRPV1TDP1TSHR
SCHEMBL31455366 0.81 ALDH1A1 (0.61) ALDH1A1HTTTRPV1TDP1TSHR
SCHEMBL31455394 0.78 MAPT (0.36) ALDH1A1TDP1HPGDMAPT
SCHEMBL31455191 0.76 GAA (0.61) ALDH1A1HTTTRPV1TSHRLMNA
SCHEMBL25384573 0.75 ABCG2 (0.54) ALDH1A1HPGDKMT2AMAPTMEN1
SCHEMBL31454989 0.75 ABCG2 (0.54) ALDH1A1HPGDKMT2AMAPTMEN1
SCHEMBL31455002 0.73 PRMT1 (0.49) HTTBRD4KMT2AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025059577-A1 SUBSTITUTED AMINOPYRIDINE COMPOUNDS FOR USE AS AKT1 INHIBITORS ATAVISTIK BIO, INC. (US) 2025-03-20 WO disclosed